Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study).
Tomoko Ueda-ConsolvoMasaaki IshidaTomoko NakamuraShuichiro YanagisawaKotaro TsuboiTaku WakabayashiAtsushi HayashiAshish Sharmanull nullPublished in: Eye (London, England) (2024)
Keyphrases